Oncology expert
In early May, Alfredo Zurlo took over the role of Chief Medical Officer at Berlin-based clinical-stage immuno-oncology company Glycotope. He joins from Mologen, where he held the position of CMO, too, and was also a member of the Executive Board.
Zurlo held various positions at Hoffmann La Roche and Roche SA, including Senior International Medical Leader Director Oncology and Medical Director Oncology. Before that, he was a medical advisor for the European Organisation for the Research and Treatment of Cancer (EORTC).
Zurlo completed his oncology and radio oncology training at the University of Rome.
Eppendorf
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest